|Articles|September 1, 2001
- Applied Clinical Trials-09-01-2001
Randomized Controlled Trials
New systems of ethical oversight for randomized controlled trials could ease the problems caused by increasingly cumbersome restrictions.
Advertisement
Articles in this issue
about 24 years ago
Connecting at the Connectathonabout 24 years ago
Patient Demands vs. Product Developmentabout 24 years ago
EU Proposes Authorization Changesabout 24 years ago
FDA Warning Lettersabout 24 years ago
The Clinical Audit in Pharmaceutical Developmentabout 24 years ago
What a Form 483 Really Meansabout 24 years ago
Effective Invvestigator Meetingsabout 24 years ago
A New Challange for Central Laboratoriesabout 24 years ago
Domenico Criscuoloabout 24 years ago
Monitoring Where Others Take HolidaysNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
